Guo Huimin, Zhang Jingze, Gao Wenyuan, Qu Zhuo, Liu Changxiao
Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University , Tianjin , China .
Pharm Biol. 2014 Sep;52(9):1141-9. doi: 10.3109/13880209.2013.879601. Epub 2014 Mar 20.
Radix Aucklandiae, the dry rhizome of Aucklandia lappa Decne (Asteraceae), enjoyed traditional popularity for its antidiarrheal effects. Although there are many investigations on its chemical constituents and pharmacologic actions, few studies explaining its activity and mechanism in gastrointestinal disorders are available.
In this paper, we focused on the effects of the methanol extract of R. Aucklandiae (RA ext) on gastrointestinal tract, so as to assess some of the possible mechanisms involved in the clinical treatment.
In vivo, in neostigmine-induced mice and normal mice, after intragastric administration, RA ext (100, 200, 300, and 400 mg/kg) was studied on gastrointestinal transit including gastric emptying and small intestinal motility. Meanwhile, in vitro, the effect of it (0.1, 0.2, 0.3, and 0.4 mg/mL) on the isolated tissue preparations of rat jejunum was also investigated, as well as costunolide and dehydrocostuslactone which were the main constituents.
In vivo, the gastric emptying increased and intestinal transit decreased after the administration of RA ext in normal mice. However, RA ext inhibited the gastric emptying and the intestinal transit throughout the concentrations in neostigmine-induced mice. In vitro, RA ext caused inhibitory effect on the spontaneous contraction of rat-isolated jejunum in a dose-dependent manner ranging from 0.1 to 0.4 mg/mL, and it also relaxed the acetylcholine chloride (Ach, 10(-5) M), 5-hydroxytryptamine (5-HT, 200 μM)-induced, and K(+) (60 mM)-induced contractions. RA ext shifted the Ca(2+) concentration-response curves to right, similar to that caused by verapamil (0.025 mM). The Ca(2+) concentration-response curves were shifted by costunolide (CO) (5.4, 8.1, and 10.8 μg/mL), dehydrocostuslactone (DE) (4.6, 6.9, and 9.2 μg/mL), costunolide-dehydrocostuslactone (CO-DE) (5.4-4.6, 8.1-6.9, and 10.8-9.2 μg/mL) to the right, similar to that caused by verapamil (0.01 mM).
These results indicate that RA ext played a spasmolytic role in gastrointestinal motility, which is probably mediated through the inhibition of muscarinic receptors, 5-HT receptors, and calcium influx. The presence of cholinergic and calcium antagonist constituents may be the compatibility of CO and DE. All these results provide a pharmacological basis for its clinical use in the gastrointestinal tract.
木香为菊科植物木香(Aucklandia lappa Decne)的干燥根状茎,因其止泻作用在传统医学中颇受青睐。尽管对其化学成分和药理作用已有诸多研究,但解释其在胃肠道疾病中的活性和机制的研究却很少。
本文聚焦于木香甲醇提取物(RA ext)对胃肠道的影响,以评估其在临床治疗中可能涉及的一些机制。
在体内实验中,对新斯的明诱导的小鼠和正常小鼠进行胃内给药后,研究RA ext(100、200、300和400mg/kg)对胃肠道转运的影响,包括胃排空和小肠运动。同时,在体外实验中,研究其(0.1、0.2、0.3和0.4mg/mL)对大鼠空肠离体组织标本的影响,以及主要成分木香烯内酯和去氢木香内酯的影响。
在体内,正常小鼠给予RA ext后胃排空增加,肠道转运减慢。然而,在新斯的明诱导的小鼠中,RA ext在所有浓度下均抑制胃排空和肠道转运。在体外,RA ext以0.1至0.4mg/mL的剂量依赖性方式对大鼠离体空肠的自发收缩产生抑制作用,并且还能松弛氯化乙酰胆碱(Ach,10⁻⁵M)、5-羟色胺(5-HT,200μM)诱导的以及K⁺(60mM)诱导的收缩。RA ext使Ca²⁺浓度-反应曲线右移,类似于维拉帕米(0.025mM)引起的右移。木香烯内酯(CO)(5.4、8.1和10.8μg/mL)、去氢木香内酯(DE)(4.6、6.9和9.2μg/mL)、木香烯内酯-去氢木香内酯(CO-DE)(5.4-4.6、8.1-6.9和10.8-9.2μg/mL)使Ca²⁺浓度-反应曲线右移,类似于维拉帕米(0.01mM)引起的右移。
这些结果表明,RA ext在胃肠道运动中发挥解痉作用,这可能是通过抑制毒蕈碱受体、5-HT受体和钙内流介导的。胆碱能和钙拮抗剂成分的存在可能是CO和DE的配伍依据。所有这些结果为其在胃肠道疾病中的临床应用提供了药理学基础。